MLTX vs PARA · $1.41B cap vs rev $5.0M
MoonLake Immunotherapeutics (MLTX) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
MoonLake Immunotherapeutics (MLTX) is a biotechnology company listed on US.
PARA (PARA) common stock.
MLTX does not have a complete income-statement cache yet.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
MLTX currently screens at market cap $1.41B. PARA currently screens at market cap $0.
Not investment advice. Open the MLTX and PARA stock pages for the full models.
Not investment advice.